Skip to content

AcrySof™ IQ PanOptix™ Toric UV IOL TFAT40 (REF TFAT40.255)Recalls & reported problems

Alcon Laboratories, Inc. · AcrySof® IQ PanOptix® Toric Trifocal intraocular lenses (IOLs) are ultraviolet absorbing foldable multifocal IOLs · Class 3 · Implant

All models of AcrySof IQ PanOptix Toric UV IOL (120)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00380652419345), received between Nov 21, 2021 and Nov 21, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Device Dislodged or Dislocated” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Device Dislodged or Dislocated1

Patient problems

  • Blurred Vision1
  • Visual Impairment1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionNov 21, 2021Device Dislodged or Dislocated; Device Dislodged or Dislocated

    ACCOUNT MANAGER ON BEHALF OF A PHYSICIAN REPORTED THAT, FOLLOWING INTRAOCULAR LENS (IOL) IMPLANTATION, THE PATIENT HAD A SURPRISE OUTCOME WITH THE IMPLANT. ADDITIONAL INFORMATION WAS RECEIVED BY THE PHYSICIAN THAT, THE PATIENT HAD EXCESSIVE ASTIGMATISM POST OP, HIGHER THAN EXPECTED MYOPIA AND ALSO MILD MOVEMENT FROM PLANNED AXIS. THE IMPLANT HAS BEEN EXCHANGED IN SECONDARY PROCEDURE WITH THE SAME POWER AND TORICITY.

    Patient problems: Blurred Vision; Visual Impairment

    MAUDE report 12849922 ↗

Other Lens, multifocal intraocular devices

All Lens, multifocal intraocular devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page